Source: Annual Congress 2006 - Airway cell biology II



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pokorski, H. Sakagami (Warsaw, Poland; Sendai, Japan). Ca²⁺/calmodulin-dependent protein kinases in carotid body chemoreceptor cells. Eur Respir J 2006; 28: Suppl. 50, 675

Member's Comments

No comment yet.

Related content which might interest you: Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries Source: Eur Respir J 2013; 41: 85-95 Year: 2013 Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids Source: Eur Respir J 2011; 37: 933-942 Year: 2011 Mitogen activated protein kinase activated protein kinase 2 regulates actin stress fiber formation in ventilator associated lung injury Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs Source: Eur Respir J 2013; 42: 28-41 Year: 2013 Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction Source: Eur Respir J 2010; 36: 1165-1173 Year: 2010 Role of adenylate kinase 4 as a new metabolic regulator of pulmonary artery smooth muscle cells under hypoxia Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Ventilation-induced activation of the mitogen-activated protein kinase pathway Source: Eur Respir J 2002; 20: 946-956 Year: 2002 Role of Ca2+-dependent protein kinases and protein phosphatase in the effect of urotensin II on the rat airway smooth muscle cells proliferation Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008 Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells Source: Eur Respir J 2001; 18: Suppl. 33, 160s Year: 2001 MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Constitutive phosphorylation of p38 mitogen activated protein kinase controls proliferation of mesothelioma cells Source: Eur Respir J 2005; 26: Suppl. 49, 225s Year: 2005 Key roles of Src family tyrosine kinases in the integrity of the pulmonary vascular bed Source: Eur Respir J 2013; 41: 3-4 Year: 2013 N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells Source: Eur Respir J 2003; 22: 43-49 Year: 2003 Endothelin-1 inhibits TASK-1 in human pulmonary artery smooth muscle cells via phospholipase C-diacylglycerol-protein kinase C-pathway Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands Source: Annual Congress 2011 - COPD: human studies Year: 2011 PKC inhibits BKCa channel activity in pulmonary arterial smooth muscle cells through multiple signaling pathways Source: Eur Respir J 2006; 28: Suppl. 50, 159s Year: 2006 Involvement of protein kinase A (PKA) in the IL-1β induced MCP-1 production in human airway smooth muscle cells Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001